CPSC Grants Local Communities $2.5M To Combat Pool Drownings

CPSC Grants Local Communities $2.5M To Combat Pool Drownings

Federal safety authorities have allocated over $2 million in grants, as part of an effort to improve safety at public pools and spas across the United States, and reduce the risk of drowning death for children.

In a press release issued on October 1, the U.S. Consumer Product Safety Commission (CPSC) announced the Pool Safely Grants for 10 states and local governments to support local efforts to prevent pool and spa drownings, and drain entrapments.

The funds are earmarked for educational programs, training, and the enforcement of pool safety regulations in the respective regions. The CPSC systematically gathers data on pool and spa safety, tracking injuries, fatalities, and identifying demographics at greatest risk. Additionally, the commission runs educational outreach to lessen drowning incidents.

Drowning poses a significant risk to young children due to their size, limited ability to swim, and lack of water safety awareness. Such incidents can happen swiftly and silently, often in mere inches of water, leaving caregivers little time to react.

Another critical safety concern that will be addressed by some of the grant money is drain entrapment, where individuals, particularly children, can become stuck underwater by the strong suction of pool or spa drains. Such entrapments can be fatal and occur when hair, limbs or clothing are caught by a drain, emphasizing the need for vigilant supervision and awareness of safety measures.

Sports-Betting-Addiction-Lawsuits
Sports-Betting-Addiction-Lawsuits

The Virginia Graeme Baker Pool and Spa Safety Act (VGB Act), signed into law by President George W. Bush in December 2007, supports these grants. The Act facilitates state and local efforts to enhance pool safety through education, training and regulatory compliance, focusing on preventing drowning and entrapment hazards.

The following communities have received grants under the VGB Act:

  • City of Seattle, Washington ($399,358)
  • Pima County, Arizona ($398,314)
  • New Orleans Health Department, Louisiana ($395,240)
  • City of Newport, Oregon ($234,981)
  • Florida Department of Health in Broward County ($200,000)
  • Florida Department of Health (whole state) Pool Safety Grant Program ($200,000)
  • City of Columbus, Ohio ($200,000)
  • City of Harlingen, Texas ($192,732)
  • City of Yuma, Arizona ($154,447)
  • City of Delray Beach, Florida ($140,205)

For more information on the Pool Safety Grant Program and the VGB Act as well as free, downloadable educational materials, individuals can visit CPSC’s website at www.PoolSafety.gov.

Written by: Darian Hauf

Consumer Safety & Recall News Writer

Darian Hauf is a consumer safety writer at AboutLawsuits.com, where she covers product recalls, public health alerts, and regulatory updates from agencies like the FDA and CPSC. She contributes research and reporting support on emerging safety concerns affecting households and consumers nationwide.




0 Comments


Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

MORE TOP STORIES

Women across the U.S. are now pursuing product liability lawsuits and medical monitoring class action claims to secure compensation for potential brain tumor symptoms and side effects linked to the use of Depo-Provera.
A Texas mother is pursuing a lawsuit against Roblox and Discord, claiming the design of the apps allow sexual predators to access and groom young children.
Federal regulators are investigating whether Dupixent increases the risk of cutaneous T-cell lymphoma (CTCL), after more than 300 adverse event reports flagged cancer diagnoses among users. The FDA’s review comes as lawsuits are being pursued nationwide, alleging Sanofi and Regeneron failed to warn that the blockbuster eczema drug could either trigger or mask the rare blood cancer.